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Sixty-four patients with primary systemic amyloidosis-53 
with two-dimensional echocardiographic features of car- 
diac involvement (Group I) and 11 without cardiac involve- 
ment (Group I&underwent Doppler echocardiographic 
assessment of left ventricular diastolic function. Pulsed 
wave Doppler recordings of left ventricular inflow velocities 
and pulmonary vein flow velocities with respiratory moni- 
toring in these patients were compared with findings in a 
normal group. 
Patients in Group I showed striking abnormalities of left 
ventricular diastolic filling when classified into subgroups 
by mean left ventricular wall thickness: early >I2 but <15 
mm; advanced 215 mm. In early amyloidosis, relaxation 
was abnormal, with decreased peak early velocity (75 2 20 
versus 86 + 16 cm/s; p <: O.Ol), increased late velocity (71 
f 22 versus 56 + 13 cm/s; p < O.Ol), decreased early to late 
The hallmark of cardiac amyloidosis is impairment of dia- 
stolic function secondary to extracellular deposition of the 
amyloid protein in the ventricular walls and septum (1). The 
hemodynamic consequence of amyloid infiltration is de- 
The standard examination for diastolic function has been 
creased ventricular distensibility, which results in the “stiff 
based on the relation between changes in ventricular pres- 
sure and volume during cardiac catheterization (4,5). Be- 
heart syndrome” (2) and leads to the symptom complex of 
congestive heart failure with preserved systolic function (3). 
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velocity ratio (1.2 f 0.6 versus 1.6 + 0.5; p < 0.01) and 
prolonged isovolumic relaxation time (87 f 15 versus 73 5 
13 ms; p < 0.01) compared with normal values. In ad- 
vanced amyloidosis, there was a restrictive filling pattern 
with a markedly shortened deceleration time (148 f 50 
versus 199 + 32 ms; p < O.OOl), decreased pulmonary vein 
peak systolic flow velocity (34 + 16 versus 54 + 12 cm/s; p 
< 0.01) and increased diastolic flow velocity (55 + 20 versus 
44 2 12 cm/s; p < 0.01) compared with normal values. 
Group II and the subgroup with early amyloidosis had 
similar flow velocity patterns. 
Thus, this study documents that in cardiac amyloidosis, 
a spectrum of diastolic filling abnormalities exists; the 
restrictive filling pattern is seen only in the advanced stages. 
(J Am Co11 Cardiol1989;13:1017-26) 
cause of limitations in this invasive technique, there has 
recently been increased emphasis on the analysis of left 
ventricular filling dynamics by noninvasive Doppler echo- 
cardiography in patients with various diseases (6-17). Re- 
Cardiac amyloidosis has been characterized as a restrictive 
cardiomyopathy on the basis of abnormal diastolic function 
(18.19). However, no study of diastolic function in a large 
cent studies (7-9) have used cardiac catheterization and 
number of patients with various degrees of cardiac amyloid- 
osis has been reported. The purpose of this study was to 
radionuclide angiography to validate the Doppler assessment 
characterize left ventricular diastolic function in 53 patients 
of left ventricular filling. 
with cardiac amyloidosis by using Doppler analysis of left 
ventricular inflow and pulmonary venous flow velocities. 
Methods 
Study patients. The study was performed on 64 consec- 
utive patients with biopsy-proved primary systemic amyloid- 
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osis who were referred for echocardiographic examination 
from July 1986 to August 1987. In all patients, a biopsy of 
subcutaneous fat, kidney, rectum or bone marrow was 
positive for amyloid; an endomyocardial biopsy was positive 
in six patients. All patients were being treated with either 
melphalan and prednisone, colchicine or vitamin E. 
Patients were excluded if they had a history of hyperten- 
sion (blood pressure >140/90 mm Hg), senility, familial or 
secondary amyloidosis (20) or regional wall abnormalities 
suggestive of coronary artery disease on two-dimensional 
echocardiography. 
Echocardiographic examination. Complete two-dimen- 
sional and spectral Doppler echocardiographic studies, in- 
cluding color flow imaging, were obtained mainly with a 
phased array system (Hewlett-Packard) with a 2.5 or 3.5 
MHz transducer. A comprehensive two-dimensional echo- 
cardiographic examination was performed as described (21). 
Parasternal short-axis views at the mid-ventricular level 
were used to derive the following M-mode measurements: 
left ventricular end-systolic and end-diastolic dimensions 
and ventricular septal and left ventricular posterior wall 
thickness. Mean left ventricular wall thickness was calcu- 
lated as half the sum of the septal and free wall thickness. 
Ejection fraction was calculated by a modification of the 
method of Quinones et al. (22). 
Doppler examination. A complete pulsed and continuous 
wave Doppler examination was performed as described (23). 
The, lowest wall filter settings were used to record flow 
velocities. A heat-sensitive nasal respirometer was used in 
most patients to record the phase of respiration simulta- 
neously with the Doppler tracing on a strip chart recorder 
with a paper speed of 50 or 100 mm/s. 
To record left ventricular inflow velocities, the apical four 
chamber view was used and the pulsed wave Doppler sample 
volume was placed at the level of the leaflet tips of the mitral 
valve. 
To record pulmonary vein flow velocity, the apical four 
chamber view was used and the pulsed wave Doppler sample 
volume was placed at the orifice of the right lower pulmo- 
nary vein. Color flow imaging was found to be useful for 
alignment and placement of the sample volume in the pul- 
monary vein. 
The time from aortic valve closure to mitral valve opening 
was obtained by using either pulsed wave Doppler interro- 
gation of left ventricular inflow and outflow tract velocities 
or, more frequently, by continuous wave Doppler interroga- 
tion directed across the outflow tract, with the beam ad- 
justed to record aortic valve closure and onset of mitral 
valve flow simultaneously (Fig. 1A). 
Doppler measurements. Left ventricular diastolic func- 
tion was assessed by analysis of left ventricular inflow and 
pulmonary vein flow velocities (24,25). All measurements 
were analyzed manually with a computer-interfaced digitiz- 
ing tablet. Mean values were obtained by averaging at least 
Figure 1. A, Diagram of normal left ventricular inflow velocities, 
showing a biphasic diastolic filling pattern with a greater peak early 
(E) and smaller peak late (A) flow velocity. Deceleration time (DT) 
is the time interval required for the E velocity to decline from its 
peak to the baseline. Isovolumic relaxation time (IVRT) is the time 
interval from aortic valve closure (AVC) to mitral valve opening 
(MVO). B, Drawing of normal pulmonary vein flow velocity, show- 
ing a biphasic forward filling pattern with slightly greater systolic (S) 
than diastolic (D) flow velocities and reverse flow with atrial 
contraction (AR). MVC = mitral valve closure. 
two beats during inspiration and two beats during expiration 
for three respiratory cycles (12 cardiac cycles). 
Peak flow velocities of the left and right ventricular 
injlows in early diastole (E) and late diastole with atria1 
jilling (A) were measured from the baseline to the maximal 
flow velocity. An E/A velocity ratio was calculated for each 
cardiac cycle. Deceleration time was measured as the time 
required for the E velocity to decrease from its peak to the 
baseline (Fig. IA). The A velocity and E/A ratio were not 
measured in patients with atria1 fibrillation or high grade 
atrioventricular (AV) block. 
Pulmonary vein forward flow velocities usually were 
classijied into two components: ventricular systole and 
diastole (Fig. IB) (26,27). Venous systolic forward flow was 
considered to occur from mitral valve closure to opening, 
and was derived by superimposing the Doppler left ventric- 
ular inflow velocity opening and closure signals onto the 
venous recordings. Diastolic forward flow was considered to 
occur from the mitral valve opening sounds to 60 ms after the 
onset of the electrocardiographic P wave. This point has 
been associated with minimal flow and onset of mechanical 
atria1 systole (27). Reverse flow velocities with atrial con- 
traction were also measured. 
Peak forward and reverse flow velocities in the pulmo- 
nary vein were measured during each component of the 
cardiac cycle. Flow velocity integrals of the venous record- 
ings were calculated by digitizing the contour of the darkest 
portion of the velocity flow pattern during each phase. The 
percent of total forward flow occurring during systole and 
the reverse flow as a percent of total forward flow were 
calculated (27). 
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Table 1. Reproducibility Data for Left Ventricular Inflow 
Standard Deviation 
lntraobserver Interobserver 
Peak E (m/s) 0.02 0.03 
Peak A (m/5) 0.03 0.01 
DT (mst 7.8 8.7 
IVRT cm,) 4.4 4.9 
DT = deceleration time: IVRT xz isovolumic relaxation time: Peak A = 
peak late diastolic flow velocity; Peak E = peak early diastolic flow velocity. 
Atrioventricular valve regurgitation. Mitral valve regur- 
gitation was described as mild, moderate or severe on the 
basis of the dimensions of the jet by color flow imaging in 
multiple orthogonal views, similar to the method of Helmcke 
et al. (28). 
Reproducibility. Intraobserver variability in assessment 
of the Doppler echocardiographic measurements was deter- 
mined by measuring 6 cardiac cycles in IO left ventricular 
inflow velocity tracings on two separate occasions (60 car- 
diac cycles). The determination of interobserver variability 
was based on analysis of the same sets of cardiac cycles by 
an independent observer. lntraobserver and interobserver 
variabilities for the left ventricular inflow velocities were 
very small (Table I). 
Doppler measurement control groups. Doppler echocar- 
diographic variables were compared with recently published 
normal values (29) for the left ventricular inflow velocities in 
40 patients with a mean (tSD) age of 39 t 11 years and a 
heart rate of 68 I 8 beats/min. Normal values for pulmonary 
vein flow velocities were obtained in 25 normal volunteers 
with a mean age of 49 2 17 years and a heart rate of 67 -C IO 
beatsimin. 
Statistical analysis. Statistical significance of the differ- 
ences between mean Doppler variables in the study sub- 
groups and in the normal groups was tested by unpaired t 
tests. Differences between Doppler variables for inspiration 
and expiration were assessed by paired t tests; p < 0.05 was 
considered to represent significance. No adjustment for 
multiple comparisons was used. The data for peak flow 
velocities, flow integrals and percent of total flow are pre- 
sented as mean values + I SD. 
Results 
Clinical and echocardiographic features. Fifty-three pa- 
tients (Group I) with typical echocardiographic features of 
cardiac involvement by amyloidosis and 1 I patients (Group 
II) with primary systemic amyloidosis but without such 
cardiac involvement were enrolled prospectively. There 
were 43 men and 21 women with a mean age of 60 2 I1 
years. Important clinical and echocardiographic characteris- 
tics of these patients are shown in Table 2. 
Subgrouping by wall thickness. Group 1 patients were 
classified by mean left ventricular wall thickness into early 
(> 12 but < IS mm) and advanced (2 15 mm) subgroups. The 
early subgroup consisted of 24 patients (12 men and 12 
women) with a mean wall thickness of 13.6 mm and a mean 
age of 57 2 9 years. Five patients (21%) had congestive heart 
failure and were taking cardiac medications (diuretic drugs, 
nitrates, digoxin or afterload-reducing agents). Three pa- 
tients (13%) had decreased systolic function detected by 
echocardiography (ejection fraction <507~‘c), and nine pa- 
tients (38%) had left atria1 enlargement. 
The advanced subgroLrp was composed of 29 patients (25 
men and 4 women) with a mean wall thickness of 16.8 mm 
Table 2. Important Clinical and Doppler Echocardiographic Features in 64 Patients 
Group I 
Total AI:E AL-A Group II 
Feature (n = 53) (n = 14) (n = 29) (n = 11) 
Age (yr) 60 % 12 57 t 9 62 t- I? 59 ? IO 
Gender (male/female) 37116 I! I? ‘514 6;5 
Heart rate (beatsimin) 82.9 -+ Il.? 83 5 II 83 + I’ 76.3 -t I7 
Systolic BP (mm Hg) II? i 18 I I5 5 20 109 ? 15 II7 ‘- II 
Diastolic BP (mm Hg) 722 I? 73 -c I2 71 k I2 72 i IO 
CHF (no.) 20 (38%) 5 121%) I5 (52%) 0 
Low ECG voltage (no.) 27 (51%) I? (50%) I5 (52%) 0 
MVWT (mm) 15.4 + 2.2 13.6 t 0.7 16.8 k 1.9 10.6 t I.1 
RVWT P 7 mm (no.) 36 (68%) IO (42%) 26 (90%) 0 
EF (‘ii) 562 I3 61 t IO 52 -+ I4 64 -t 8 
I.,4 (mm) 44 5 8 42 z 6 46 -+ 9 36 ? 3 
MR (no.) 45 (85%) IX (75%) 27 (93%) 0 
Data are reported as mean values ? SD. AL-A = advanced cardiac amyloidosis: AL-E = early cardiac 
amyloidosis: BP = blood pressure: CHF = congestive heart failure: ECG = electrocardiographic; EF = ejection 
fraction: LA = size of left atrium: MR = mitral regurgitation: MVWT = mean ventricular wall thickness: no. = 
number of patients: RVWT = right ventricular wall thicknehs. 
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Table 3. Left Ventricular Inflow Velocity in 64 Patents and 40 Normal Subjects 
Peak E Peak A DT 
Group n (cm/s) (cm/s) E/A tmsl 
Normal 40 862 16 56 + 13 1.6 + 0.5 199 ? 32 
Group I 53 84 ? 24 65 ? 28t 1.6 + 1.0 163 + 50t 
AL-E 24 75 + 20: 71 2 22t 1.2 + 0.6: 181 + 43 
AL-A 29 91 2 25t 59 ? 32 2.0 + 1.2$ 148 + 50tS 
Group II 11 71 + 15:fi 71 ? 17t 1.0 c 0.4Q 180 ? 31 
IVRT* 
(ms) 
732 13 
84 ? 18+ 
87 ? 15: 
82 ? 20 
762 12 
*Isovolumic relaxation time (IVRT) obtained in 38 patients in Group I(16 early cardiac amyloidosis; 22 advanced 
cardiac amyloidosis) and 6 patients in Group II: +p < 0.05 for difference from normal; $p < 0.01 for difference 
between early and advanced subgroups: Pp < 0.05 for difference between Group I and Group II. Data are reported 
as mean values + SD. E/A = peak flow velocity ratio of left and right ventricular inflows in early diastole and late 
diastole with atrial filling: other abbreviations as in Tables 1 and 2. 
and a mean age of 62 * 12 years. Fifteen patients (52%) had 
congestive heart failure, 11 (38%) had decreased systolic 
function and were taking cardiac medications and 15 (52%) 
had left atria1 enlargement. Four patients had an abnormal 
rhythm with either atria1 fibrillation or high grade AV block. 
Group II patients (6 men and 5 women) had a mean wall 
thickness of 10.6 mm and no two-dimensional echocardio- 
graphic evidence of cardiac amyloidosis. None of these 
patients had a history of congestive heart failure. 
Left Ventricular Diastolic Function 
Left ventricular inflow velocity. Analyzable left ventric- 
ular inflow velocity tracings were available for all 64 pa- 
tients. The isovolumic relaxation time was obtained in 42 
patients. 
Group I (Table 3). In this group with increased mean left 
ventricular wall thickness, there was at least one abnormal 
inflow velocity value (by -tl SD) in 47 (89%) of the 53 
patients. For the group as a whole, peak E velocity was not 
different from normal, peak A velocity was increased and El 
A ratio was not different from normal. The deceleration time 
was decreased, but the isovolumic relaxation time was 
prolonged when compared with normal values. However, 
when the Group I patients were classified into early and 
advanced subgroups, a more uniform diastolic profile 
emerged. 
The early subguolcp showed a prolonged isovolumic re- 
laxation time, decreased peak E velocity, increased peak A 
velocity and decreased E/A ratio compared with normal. 
The deceleration time usually was normal in this subgroup, 
although it was prolonged in three patients (Fig. 2A and B). 
The advanced subgroup showed a markedly shortened 
deceleration time compared with normal. Peak E velocity 
and E/A ratio were similar to normal, although they were 
increased in several patients (Fig. 3A and B). Isovolumic 
relaxation time was not different from normal (Fig. 30 Peak 
E velocity and deceleration time in this subgroup were 
different from those in the early subgroup. 
Group II. In this group of 11 patients (with primary 
systemic amyloidosis without cardiac involvement), the in- 
flow velocities were abnormal in 8 (73%). Peak E velocity 
was decreased, peak A velocity was increased and E/A ratio 
was decreased compared with normal values (Table 3). 
Deceleration time and isovolumic relaxation time were not 
different from normal. 
Pulmonary vein flow velocity (Table 4). Analyzable pul- 
monary vein flow velocity tracings were recorded in 29 
(55%) of the 53 patients with cardiac amyloidosis (Group I); 
none of the Group II patients (without cardiac amyloidosis) 
had analyzable tracings. Overall, Group I patients showed 
an abnormal pulmonary vein flow velocity profile, with 
decreased peak systolic and increased diastolic forward 
filling. The advanced subgroup showed markedly decreased 
peak systolic filling, increased peak diastolic filling and 
decreased flow velocity integral occurring during systole 
compared with normal (Fig. 3D). The early subgroup 
showed normal peak systolic and diastolic flow velocities, 
although in two patients, peak systolic velocity was signifi- 
cantly (>1.7-fold) greater than diastolic flow velocity (Fig. 
2C). In 10 patients, atria1 reversal flow velocities were 
greater than normal (21 cm/s) (Fig. 3D). In these 10 patients, 
left atria1 size (42 5 8 mm) was not significantly different 
from left atria1 size (44 f 8 mm) in patients without abnormal 
atria1 reversal flow velocities. There was no significant 
change in pulmonary vein flow velocity variables between 
inspiration and expiration. 
Atrioventricular valve regurgitation. Mitral regurgitation 
was detected in 45 (85%) of the 53 Group I patients with 
cardiac amyloidosis (18 patients in the early subgroup and 27 
in the advanced subgroup). The degree was mild in all 18 
patients in the former subgroup and in 21 of the latter; it was 
moderate in 5 and severe in 1 patient in the advanced 
subgroup. When the degree of mitral regurgitation was 
considered as a scale variable, the difference between early 
and advanced subgroups was significant (p < 0.05). Mild 
mitral regurgitation also was detected in 6 (55%) of the I1 
Group II patients without two-dimensional echocardio- 
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graphic evidence of cardiac amyloidosis. When the six 
patients with moderate or severe regurgitation in the ad- 
vanced subgroup were excluded, deceleration time was still 
markedly shorter (156 f 53 ms; p < 0.01) than normal. 
Systolic function. Fifteen patients (28%) in Group I with 
decreased systolic function (ejection fraction ~50%) had a 
shorter deceleration time (124 ? 25 versus 178 2 49 ms; p < 
0.001) and increased E/A ratio (2.5 2 1.2 versus 1.25 r 0.7; 
p < 0.001) than did patients in Group I with normal systolic 
function. When patients with decreased systolic function 
were excluded from analysis. the advanced subgroup still 
showed a shortened deceleration time (166 2 57 ms; p < 
0.03), and the early subgroup showed a decreased E/A ratio 
(1.1 2 0.4; p < 0.01) and prolonged isovolumic relaxation 
time (91 ? 12 ms; p < 0.01) compared with normal. 
Discussion 
Diastolic function abnormality in cardiac amyloidosis. 
The type of diastolic function abnormality in cardiac amyloid- 
osis has not been clearly characterized because only small 
Figure 2. Abnormal relaxation flow pattern of left ventric- 
ular inflow in a subgroup with early cardiac amyloidosis. 
A, Pulsed wave Doppler recording of a left ventricular 
inflow profile with decreased peak E velocity and in- 
creased peak A velocity. The E/A ratio was decreased 
(0.5) and deceleration time (DT) was prolonged (300 ms). 
B, Continuous wave Doppler recording of the aortic 
valve, with simultaneous mitral valve inflow profile. Note 
that aortic closure (AC) and mitral opening (MO) sounds 
are well defined and isovolumic relaxation time is mark- 
edly prolonged (140 ms). C, Pulsed wave Doppler record- 
ing of right lower pulmonary vein flow profile with in- 
creased peak forward systolic (S) and decreased diastolic 
(D) flow velocities and normal reversal of atrial filling 
(AR). Exp. = expiration: Insp. = inspiration. 
numbers of patients were studied in previous series (2,30,31). 
Traditionally, cardiac amyloidosis has been considered to be 
a “restrictive cardiomyopathy” showing the “square root 
sign” (19); however, the reported frequency of this hemody- 
namic pattern has varied. Swanton et al. (30) described four of 
five patients with cardiac amyloidosis with this sign, whereas 
Meaney et al. (3 1) found this in only one of three patients. In 
contrast, other investigators (32,33), using digitized M-mode 
echocardiography and left ventriculography, found relaxation 
abnormalities with prolonged isovolumic relaxation time and 
uniformly delayed left ventricular diastolic filling volume and 
filling rate. Atrial systolic failure secondary to amyloid infil- 
tration of the atria also was suggested (34) to influence the 
impaired diastolic filling seen in this condition. 
Left ventricular filling in cardiac amyloidosis. Recently, 
measurements of left and right ventricular inflow velocities 
by Doppler echocardiography have been useful in assessing 
diastolic function of the left and right ventricles in different 
diseases (9-17.35). Some investigators (36-38) have shown 
that measuring AV and venous flow velocities with respira- 
tory monitoring may be useful in distinguishing restrictive 
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Figure 3. Restrictive flow patterns of left ventricular inflow in the 
subgroup with advanced cardiac amyloidosis. A, Pulsed wave 
Doppler recording of a left ventricular inflow profile with an in- 
creased E/A ratio (3.7) and short deceleration time (120 ms). B, 
Pulsed wave Doppler recording of a left ventricular inflow profile 
with a normal E/A ratio and short deceleration (DT) time (130 ms). 
C, Continuous wave Doppler recording of the aortic valve with 
simultaneous mitral valve flow profile. Note the normal isovolumic 
relaxation time (65 ms). D, Pulsed wave Doppler recording of a right 
lower pulmonary vein flow profile with decreased peak forward 
systolic (S) and increased peak diastolic (D) velocities and reversal 
of atrial filling (AR). Note that the left-sided flow velocities are 
influenced minimally by respiration. Abbreviations as in Figure 2. 
cardiomyopathy from constrictive pericardial disease and 
cardiac tamponade from pericardial effusion. Using mea- 
surements of left ventricular inflow and pulmonary vein flow 
velocities, we have shown that there is a spectrum of left 
ventricular diastolic filling abnormalities in a large group of 
patients with cardiac amyloidosis. 
Degree of infiltration. In a previous series of 132 patients 
with biopsy-proved systemic amyloidosis seen at our insti- 
tution, Cueto-Garcia et al. (3,39) found that the echocardio- 
graphic variable of mean left ventricular wall thickness is a 
useful predictor of cardiac involvement and subsequent 
prognosis. Patients with wall thickness >12 but cl.5 mm 
(similar to our early subgroup) had a mean survival of 1.3 
years; those with wall thickness >15 mm (similar to our 
advanced subgroup) had a mean survival of only 0.4 year. 
Our study demonstrates that diastolic filling abnormalities 
are related to the degree of amyloid infiltration as measured 
by wall thickness (24). 
Left ventricular inflow velocity. The early subgroup had 
decreased peak E velocity, increased peak A velocity, 
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Table 4. Pulmonary Vein Peak Flow Velocity and Flow Velocity Integrals in 29 Group I Patients 
and ?5 Normal Subjects 
s D Q FFVI Reverse FVI as 
Group n (cm/s) (cm/s) Systole % Total FFVI 
Normal 25 54 ? 12 442 I! 62 2 7.1 IO ? 4 
Group I 29 41 ? 17* S? + 17: 41 t 19* 12 + 12 
.4L-E 13 50 2 1% 482 14 56 2 II$ 10 + 6 
.+.L-A 16 34 + 16* 55 ? 20* 40 + 21” 13 t 15 
*p < 0.01 for difference from normal: tp < 0.05 for difference from normal: Sp < 0.05 for difference between early 
cardiac amyloidosis and advanced cardiac amyloidosis. Data are reported as mean values + SD. D = diastolic flow 
velocity: FFVI = forward flow velocitv interval: FVI = flow velocity interval: S = systolic flow velocity; other 
.rbbreviations as in Table 2 
decreased E/A ratio, prolonged isovolumic relaxation time 
and normal deceleration time. This velocity profile suggests 
abnormal or prolonged relaxation, with an emphasis on 
filling with atrial contraction (24). This pattern is similar to 
the Doppler variables of a decreased E/A ratio and mitral 
deceleration rate and invasive or nuclear imaging variables 
of a prolonged time constant (tau), prolonged isovolumic 
relaxation time and decreased peak early rate of diastolic 
cavity filling reported in systemic hypertension (8,11,12,40), 
left ventricular hypertrophy (16,41), hypertrophic cardiomy- 
opathy (14,15,17.40), congestive cardiomyopathy (7,8,13, 
40,42) and coronary artery disease (7,9.10,40.42). Hirota et 
al. (43) described abnormal relaxation as showing a pro- 
longed time constant (tau) in patients with idiopathic restric- 
tive cardiomyopathy, and St. John Sutton et al. (32) reported 
prolonged isovolumic relaxation time and decreased peak 
early rate of diastolic cavity filling with use of digitized 
M-mode echocardiography in patients with cardiac amyloid- 
osis. 
In contrast to our early subgroup with cardiac amyloid- 
osis, the subgroup with advanced amyloidosis showed a 
markedly shortened deceleration time and normal isovolu- 
mic relaxation time (24). The shortened deceleration time is 
the result of the rapidly increasing early left ventricular 
diastolic pressure for a small change in volume and an abrupt 
termination of filling seen classically in restrictive cardiomy- 
opathy (dip and plateau) (29). In 10 patients, Plehn et al. (34) 
found increased left ventricular inflow E/A ratio in cardiac 
amyloidosis compared with other conditions with myocar- 
dial hypertrophy. a finding similar to the findings in our 
advanced subgroup. These investigators concluded that the 
decrease in peak A velocity was secondary to amyloid 
infiltration of the atria, resulting in atrial systolic failure. 
However, they did not record pulmonary vein flows, which 
provide an indirect assessment of left atrial filling dynamics 
(26). 
Patients with systemic amyloidosis without cardiac in- 
volvement (Group If) had filling patterns similar to those in 
the early subgroup with a decreased E/A ratio and normal 
deceleration time. This finding suggests that either there are 
occult abnormalities of left ventricular diastolic function in 
patients without obvious cardiac amyloid involvement by 
two-dimensional echocardiography or that other factors (for 
example, age) may influence the filling patterns (7.44-47). 
Pulmonary vein flow velocity. Pulmonary vein flow was 
distinctly abnormal in the advanced subgroup, with de- 
creased systolic flow velocity and increased diastolic flow 
velocity compared with normal values. A close relation was 
noted between left ventricular inflow and pulmonary vein 
flow velocities: that is, increased peak E velocity and 
increased peak diastolic flow velocity. The increase in 
pulmonary vein diastolic flow may result from a rapid 
decrease in left atrial filling after the increased rapid filling (E 
velocity) into the stiff ventricle (26). The early subgroup 
showed a normal pulmonary vein flow pattern; however. in 
two patients, peak systolic flow velocities were much greater 
than diastolic flow velocities. The increased pulmonary vein 
systolic flow velocity may result from the decrease in left 
atrial filling secondary to atria1 relaxation after increased 
atrial systole (A velocity) (26). The prominent atrial rever- 
sals in the pulmonary vein (10 patients) argue against atrial 
systolic failure as a mechanism for the impaired diastolic 
filling in cardiac amyloidosis because the left atrium is able 
to contract. 
Atrioventricular valve regurgitation. Roberts and Wailer 
(I) found amyloid deposits in the valvular endocardium at 
autopsy in 46 (8%) of 54 patients with cardiac amyloidosis. 
In our study. 85% of the patients had mitral regurgitation, 
usually mild. Mitral regurgitation was detected more fre- 
quently in the advanced subgroup than in the early sub- 
group. but the severity was mild in 77%. moderate in 19% 
and severe in 4% of patients in the advanced subgroup with 
mitral regurgitation. Takenaka et al. (14) reported that sig- 
nificant mitral regurgitation masked the increased peak A 
velocity pattern seen in patients with hypertrophic cardio- 
myopathy secondary to increased transmitral flow. In our 
study. the degree of mitral regurgitation may have played a 
role in influencing left ventricular filling velocities; however, 
with the exclusion of patients with moderate or severe mitral 
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Figure 4. Serial left ventricular inflow patterns (pulsed 
wave Doppler recordings) in a 63 year old woman wilh 
symptomatic cardiac amyloidosis whose pattern 
changed from abnormal relaxation to “pseudonorma- 
lization” over 5.5 months. Left, Decreased E/A ratio 
(0.5) and prolonged deceleration time (DT) (250 ms). 
Right, At 5.5 months later, E/A ratio (I .O) and decel- 
eration time (190 ms) are normal. 
regurgitation, there were no major changes in the filling 
variables. 
Systolic function. The association between decreased 
ejection fraction and restrictive Doppler indexes (decelera- 
tion time ~150 ms) is not surprising because as cardiac 
amyloidosis progresses, both diastolic function (as measured 
by wall thickness) and systolic function become impaired. 
When the 14 patients with decreased systolic function were 
excluded from analysis, the differences in diastolic filling 
between the early and advanced subgroups were still 
present. In a recent study (35), patients with congestive 
cardiomyopathy and decreased systolic function also 
showed a predominance of diastolic dysfunction from re- 
duced left ventricular chamber compliance and elevated 
filling pressures, resulting in a restrictive Doppler pattern. 
Evolution of disease. In our study, six patients (11%) 
with definite cardiac amyloidosis (Group I) by echocardiog- 
raphy showed a completely normal left ventricular inflow 
filling pattern. This finding most likely represents a transition 
stage of diastolic impairment (35). With gradual increases in 
restriction and filling pressures, there is a pseudonormaliza- 
tion of the inflow velocity and masking of the abnormal 
relaxation. Gradually, with progression of the disease, there 
is evolution of the restrictive pattern. In several patients who 
had serial follow-up study by Doppler examination, we 
documented a change of filling pattern from abnormal relax- 
ation to “normal” to one of restriction concomitant with 
increased symptoms (Fig. 4). The early subgroup showed a 
normal deceleration time despite prolonged isovolumic re- 
laxation time and decreased E/A ratio. These findings are in 
contrast to the usual pattern observed in coronary artery 
disease (7,9,10,40,42) and left ventricular hypertrophy 
(16,41); they suggest that even in the early forms of cardiac 
amyloidosis, there may be mild restriction. 
Mechanisms for abnormal diastolic filling. The mecha- 
nisms for the abnormalities in diastolic filling in early and 
advanced cardiac amyloidosis have not been established. 
We have shown that wall thickness (as a measure of amyloid 
infiltration) correlates with abnormal filling patterns in con- 
trast to physiologic left ventricular hypertrophy (48). Relax- 
ation abnormalities are one of the earliest signs of cardiac 
dysfunction in many disease states (41). We can only spec- 
ulate that, in early amyloidosis, there may be a lesser 
infiltration of the amyloid fibers within the myocardium but 
that it is sufficient to alter the relaxation process and affect 
calcium movement within the cells or to cause inhomogene- 
ity between contraction and relaxation of the myocardial 
cells (49,50). This sequence results in an abnormality of 
relaxation in early diastole and delayed early diastolic filling, 
with a shift to filling during atria1 contraction as a compen- 
satory response (10,35). In contrast, in advanced amyloid- 
osis, the left ventricle becomes very stiff as a result of 
greater infiltration of the myocardium by amyloid fibers and 
loss of myocardial cells as a result of pressure necrosis (32). 
These events produce a sudden decrease in compliance of 
the ventricle in early diastole because of the restrictive 
process, accounting for the “square root sign” (30,31,35). 
Limitations of this study. Endomyocardial b.iopsy to 
confirm the diagnosis of cardiac amyloidosis was not per- 
formed in the majority of patients. However, in previous 
work at our institution (3,39) the typical echocardiographic 
findings of cardiac amyloidosis have always been confirmed 
in those patients who had an autopsy or cardiac biopsy. 
A major limitation of this study is that we did not obtain 
simultaneous invasive hemodynamic and Doppler data. 
However, Appleton et al. (29,35) have corroborated Doppler 
profiles with invasive hemodynamic studies in patients with 
coronary artery disease, congestive cardiomyopathy or re- 
strictive cardiomyopathy. 
Diastolic jilling velocities can be influenced by many 
factors, including preload, afterload, heart rate, left ventric- 
ular and atria1 compliance and patient age (5,44-47,51). We 
have found that wall thickness (measured by echocardiog- 
raphy) is an important determinant of diastolic function but 
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is not the only factor. In recent studies (5.47: Klein et al.. 
read at the annual meeting of the Canadian Cardiovascular 
Society, Montreal, October 26 to 29, 19881, increasing age 
has been shown to have a major influence on left ventricular 
diastolic function, with older patients having decreased E/A 
ratio, increased deceleration time and prolonged isovolumic 
relaxation time. In our study. the mean age of the normal 
group was younger than that of the study patients because 
we did not use age-matched controls (29). The age-related 
effects could have been responsible for the abnormal relax- 
ation pattern seen in the early subgroup; however. this group 
was slightly younger than the advanced subgroup (p < 0.08). 
Furthermore, age certainly would not account for the restric- 
tive pattern seen in the advanced subgroup. 
There was swnr overlap in the filling patterns in the earl! 
and adwnced suh~roups. This most likely resulted from the 
arbitrary separation of these groups (>12 but ~15 mm and 
215 mm, respectively) by mean left ventricular wall thick- 
ness. 
9. Spirit0 P. Maron BJ. Bonow RO. Noninvasive assessment of left ventric- 
ular diastolic function: comparative analysis of Doppler echocardio- 
graphic and radionuclide angiographic techniques. J Am Coil Cardiol 
1986:7:51X-26. 
IO. Fujii J. Yaraki Y. Sawada H. Aizawsa T, Watanabe H. Kato K. Nonin- 
vastve assessment of left and right ventrtcular filling in myocardial 
mfarctton with a two-dimensional Doppler echocardiographic method. J 
Am Coil Cardiol 1985:5:1155~0. 
II. Phillips RA. Coplan NL, Krakotf LR. et al. Doppler echocardiographic 
analysis of left ventricular filling in treated hypertensive patients. J Am 
Coil Cardtol 19X7:9:317-22. 
I!. Smder AR. Gidding SS. Rocchini AP. et al. Doppler evaluation of left 
ventricular diastolic filling in children vvith systemic hypertension. Am 3 
Cardiol 1985:56:Y21-6. 
13. Takenaka K. Dabestani A. Gardin JM. et al. Pulsed Doppler echocardio- 
graphic study of left ventricular filling in dilated cardiomyopathy. Am J 
Cardtol 1986%: 143-7. 
14. Takenaka K. Dabestani A. Gardm JM, et al. Left ventricular filling in 
hypertrophic cardiomyopathy: a pulsed Doppler echocardiographic 
study. J Am Coll Cardiol 1986:7:1?63-71. 
15. 
Clinical implications. This study clearly demonstrates 
that there exists a continuum of diastolic filling abnormalities 
in patients with cardiac amyloidosis. We found that the 
degree of cardiac infiltration (as determined by wall thick- 
ness) markedly influences diastolic filling in this disease. We 
believe that, as diastolic function deteriorates. the flow 
velocity pattern may evolve from the abnormal relaxation 
pattern of early cardiac amyloidosis through a “pseudo- 
normal” pattern to the restrictive pattern of advanced dis- 
ease. These results suggest that diastolic dysfunction in 
cardiac amyloidosis shows a spectrum of abnormalities that 
could be followed serially by Doppler echocardiography. 
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